Eales disease
Eales disease is an idiopathic, inflammatory condition that primarily affects the retina of the eye. It is characterized by recurrent episodes of retinal vasculitis, peripheral retinal ischemia, and neovascularization. The disease predominantly affects young adults, particularly males, and can lead to significant visual impairment if not managed appropriately.
Etiology
The exact cause of Eales disease remains unknown. However, it is believed to be associated with an abnormal immune response. Some studies suggest a possible link to tuberculosis due to the presence of Mycobacterium tuberculosis DNA in the ocular fluids of some patients.
Pathophysiology
Eales disease progresses through three stages:
- Inflammatory stage: Characterized by periphlebitis and retinal vasculitis.
- Ischemic stage: Marked by retinal ischemia and capillary non-perfusion.
- Proliferative stage: Involves neovascularization, which can lead to vitreous hemorrhage and tractional retinal detachment.
Clinical Features
Patients with Eales disease typically present with:
On examination, signs may include:
Diagnosis
Diagnosis is primarily clinical, supported by imaging studies such as:
Treatment
Management of Eales disease includes:
- Corticosteroids to reduce inflammation
- Anti-tubercular therapy if associated with tuberculosis
- Laser photocoagulation to manage neovascularization
- Vitrectomy for non-resolving vitreous hemorrhage or retinal detachment
Prognosis
The prognosis of Eales disease varies. Early diagnosis and appropriate treatment can help preserve vision. However, complications such as recurrent vitreous hemorrhage and retinal detachment can lead to significant visual impairment.
Related Pages
Categories

This article is a ophthalmology stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian